Human papillomavirus type 16 E6, E7, and L1 variants in cervical cancer in Indonesia, Suriname, and the Netherlands

Gynecologic Oncology

Volumn 94, Issue 2, 2004, Pages 488-494

  De Boer, Marjon A ^a   Peters, Lex A W ^a   Aziz, Mohammed Farid ^b   Siregar, Budiningsih ^c   Cornain, Santoso ^c   Vrede, M Albert ^d   Jordanova, Ekaterina S ^a   Kolkman Uljee, Sandra ^a   Fleuren, Gert Jan ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF INDONESIA   (Indonesia)

^c Faculty of Medicine   (Indonesia)

^d ACADEMIC HOSPITAL PARAMARIBO   (Suriname)

Author keywords

Cervical cancer; Human papillomavirus type 16; Variant

Indexed keywords

ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; FEMALE; GEOGRAPHIC DISTRIBUTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INDONESIA; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; NETHERLANDS; PRIORITY JOURNAL; RISK ASSESSMENT; SEQUENCE ANALYSIS; SURINAME; UTERINE CERVIX CARCINOMA; VIRUS CARCINOGENESIS; VIRUS IDENTIFICATION; VIRUS TYPING; WART VIRUS;

BASE SEQUENCE; CAPSID PROTEINS; DNA, VIRAL; FEMALE; HUMANS; INDONESIA; NETHERLANDS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; REPRESSOR PROTEINS; SURINAME; UTERINE CERVICAL NEOPLASMS;

EID: 3543066382     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.05.037     Document Type: Article

References (39)

1. Parkin D.M., Pisani P., Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int. J. Cancer. 80:1999;827-841
2. Tjindarbumi D., Mangunkusumo R. Cancer in Indonesia, present and future. Jpn. J. Clin. Oncol. 32:2002;S17-S21. [Suppl.]
3. Wheeler C.M., Yamada T., Hildesheim A., Jenison S.A. Human papillomavirus type 16 sequence variants: identification by E6 and L1 lineage-specific hybridization. J. Clin. Microbiol. 35:1997;11-19
4. Sibuea W.H. Cancer in Mangunkusumo Hospital, Jakarta. Gan To Kagaku Ryoho. 27(Suppl. 2):2000;549-559
5. Sutnick A.I., Gunawan S. Cancer in Indonesia. JAMA. 247:1982;3087-3088
6. Krul E.J., Peters L.A., Vandenbroucke J.P., Vrede A., van Kanten R.W., Fleuren G.J. Cervical carcinoma in Surinam. Incidence and staging of cervical carcinoma between 1989 and 1994. Cancer. 77:1996;1329-1333
7. Munoz N. Human papillomavirus and cancer: the epidemiological evidence. J. Clin. Virol. 19:2000;1-5
8. Giannoudis A., Herrington C.S. Human papillomavirus variants and squamous neoplasia of the cervix. J. Pathol. 193:2001;295-302
9. Xi L.F., Koutsky L.A., Galloway D.A., et al. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 89:1997;796-802
10. Hildesheim A., Wang S.S. Host and viral genetics and risk of cervical cancer: a review. Virus Res. 89:2002;229-240
11. Seedorf K., Krammer G., Durst M. Human papillomavirus Type 16 DNA sequence. Virology. 145:1985;181-185
12. Yamada T., Manos M.M., Peto J., et al. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J. Virol. 71:1997;2463-2472
13. Chan S.Y., Ho L., Ong C.K., et al. Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind. J. Virol. 66:1992;2057-2066
14. Ho L., Chan S.Y., Burk R.D., et al. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J. Virol. 67:1993;6413-6423
15. Etherington I.J., Ellis J.R., Luesley D.M., Moffitt D.D., Young L.S. Histologic and immunologic associations of an HPV 16 variant in LoSIL smears. Gynecol. Oncol. 72:1999;56-59
16. Hu X., Pang T., Guo Z., Ponten J., Nister M., Bernard A.G. Oncogene lineages of human papillomavirus type 16 E6, E7 and E5 in preinvasive and invasive cervical squamous cell carcinoma. J. Pathol. 195:2001;307-311
17. Picconi M.A., Alonio L.V., Sichero L., et al. Human papillomavirus type-16 variants in Quechua aboriginals from Argentina. J. Med. Virol. 69:2003;546-552
18. Villa L.L., Sichero L., Rahal P., et al. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J. Gen. Virol. 81:2000;2959-2968
19. Matsumoto K., Yoshikawa H., Nakagawa S., et al. Enhanced oncogenicity of human papillomavirus type 16 (HPV 16) variants in Japanese population. Cancer Lett. 156:2000;159-165
20. Stephen A.L., Thompson C.H., Tattersall M.H., Cossart Y.E., Rose B.R. Analysis of mutations in the URR and E6/E7 oncogenes of HPV 16 cervical cancer isolates from central China. Int. J. Cancer. 86:2000;695-701
21. Berumen J., Ordonez R.M., Lazcano E., et al. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J. Natl. Cancer Inst. 93:2001;1325-1330
22. Kleter B., Van Doorn L.J., Schrauwen L., et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J. Clin. Microbiol. 37:1999;2508-2517
23. Zehbe I., Wilander E., Delius H., Tommasino M. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res. 58:1998;829-833
24. Zehbe I., Tachezy R., Mytilineos J., et al. Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes. Int. J. Cancer. 94:2001;711-716
25. Song Y. Major sequence variants in E7 gene of human papillomavirus type 16 from cervical cancerous and noncancerous lesions of Korean women. Gynecol. Oncol. 66:1997;275-281
26. Hildesheim A., Schiffman M., Bromley C., et al. Human papillomavirus type 16 variants and risk of cervical cancer. J. Natl. Cancer Inst. 93:2001;315-318
27. Kammer C., Tommasino M., Syrjanen S., et al. Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: implications for cervical disease. Br. J. Cancer. 86:2002;269-273
28. Radhakrishna Pillai M., Sreevidya S., Pollock B.H., Jayaprakash P.G., Herman B. Human papillomavirus type 16 E6 and E7 gene variations in Indian cervical cancer. Gynecol. Oncol. 87:2002;268-273
29. Nindl I., Rindfleisch K., Lotz B., Schneider A., Durst M. Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer. Int. J. Cancer. 82:1999;203-207
30. Bontkes H.J., van Duin M., de Gruijl T.D., et al. HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants. Int. J. Cancer. 78:1998;166-171
31. Chan P.K., Lam C.W., Cheung T.H., et al. Human papillomavirus type 16 intratypic variant infection and risk for cervical neoplasia in southern China. J. Infect. Dis. 186:2002;696-700
32. Fujinaga Y., Okazawa K., Nishikawa A., et al. Sequence variation of human papillomavirus type 16 E7 in preinvasive and invasive cervical neoplasias. Virology. 9:1994;85-92
33. Smits H.L., Traanberg K.F., Krul M.R., et al. Identification of a unique group of human papillomavirus type 16 sequence variants among clinical isolates from Barbados. J. Gen. Virol. 75(Pt. 9):1994;2457-2462
34. van Duin M., Snijders P.J., Vossen M.T. Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis. J. Gen. Virol. 81:2000;317-325
35. Stoppler M.C., Ching K., Stoppler H., Clancy K., Schlegel R., Icenogle J. Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J. Virol. 70:1996;6987-6993
36. Apple R.J., Erlich H.A., Klitz W., Manos M.M., Becker T.M., Wheeler C.M. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nat. Genet. 6:1994;157-162
37. Ellis J.R., Keating P.J., Baird J., et al. The association of an HPV 16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nat. Med. 1:1995;464-470
38. Matsumoto K., Yasugi S., Nakagawa S., et al. Human papillomavirus type 16 E6 variants and HLA class II alleles among Japanese women with cervical cancer. Int. j. cancer. 106:2003;919-922
39. Hilleman M.R. Overview of vaccinology with special reference to papillomavirus vaccines. J. Clin. Virol. 19:2000;79-90